<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) is antibody-induced <z:mp ids='MP_0005048'>thrombosis</z:mp>, whose diagnostic basis is the obligatory presence of serological markers along with clinical manifestations </plain></SENT>
<SENT sid="1" pm="."><plain>Its laboratory markers are <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPAs), the highest informative value has been proven for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA), <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies, fl-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 </plain></SENT>
<SENT sid="2" pm="."><plain>LA should be determined at a laboratory in accordance with the recommendations of the International Society on <z:mp ids='MP_0005048'>Thrombosis</z:mp> and Hemostasis </plain></SENT>
<SENT sid="3" pm="."><plain>Obstetric abnormality in APS should be regarded as a thrombotic complication and its management in this case does not differ from that and prevention of <z:mp ids='MP_0005048'>thrombosis</z:mp>, aPAs may be detectable in various illnesses, but their blood presence is not an indication for immunosuppressive therapy </plain></SENT>
<SENT sid="4" pm="."><plain>The paper describes a case of primary APS in a female patient </plain></SENT>
</text></document>